text
"['\n2. 주요 제품 및 서비스\n가. 매출에 관한 사항(1) 주요 제품, 서비스 등의 현황\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 (단위 : 천원,%)\n사업부문\n주요품목\n금액\n비중\n의약품\n\xa0리피다운캡슐60mg 90C(PTP)\n483,345\n4.7\n\xa0레바미드정100MG 300T\n208,753\n2.0\n\xa0리피스림캡슐120mg300C\n179,646\n1.8\n\xa0기타\n7,970,859\n77.8\n소계\n8,842,603\n86.3\n메디컬\n\xa0Triathlon Femoral Component\xa0\n71,125\n0.7\n\xa0ATTUNE CR FEMORAL CEM\n69,377\n0.7\n\xa0LCS COMPLETE FEM CEM L MED\n37,428\n0.4\n\xa0기타\xa0\n1,229,210\n12.0\n소계\n1,407,140\n13.7\n합계\n10,249,743\n100.0\n나. 주요 제품 등의 가격 변동추이\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0(단위 : 원)\n사업부문\n품목\n당반기\n전기\n의약품\n\xa0리피다운캡슐60mg 90C(PTP)\n32,922\n32,922\n\xa0레바미드정100MG 300T\n26,680\n26,680\n\xa0리피스림캡슐120mg300C\n105,000\n105,000\n메디컬\n\xa0Triathlon Femoral Component\n526,680\n526,680\n\xa0ATTUNE CR FEMORAL CEM\n544,800\n544,800\n\xa0LCS FEMORAL COMPONENT\n541,040\n541,040\n']"
